Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian S Ray

Showing results (11-20 of 103) with videos related to

Pageof 11
Sort By:
The Journal of Biological Chemistry|August 15, 2002
Mechanistic studies to understand the progressive development of resistance in human immunodeficiency virus type 1 reverse transcriptase to abacavirAdrian S Ray, Aravind Basavapathruni, Karen S Anderson
Current Opinion in Drug Discovery & Development|July 3, 2010
HCV NS5B polymerase inhibitorsWilliam J Watkins, Adrian S Ray, Lee S Chong
Toxicological Sciences : an Official Journal of the Society of Toxicology|November 3, 2016
Role of Mitochondrial Toxicity in BMS-986094-Induced ToxicityJoy Y Feng, Chin H Tay, Adrian S Ray
Antiviral Research|December 8, 2015
Tenofovir alafenamide: A novel prodrug of tenofovir for the treatment of Human Immunodeficiency VirusAdrian S Ray, Marshall W Fordyce, Michael J M Hitchcock
Biochemical Pharmacology|September 29, 2004
Effective metabolism and long intracellular half life of the anti-hepatitis B agent adefovir in hepatic cellsAdrian S Ray, Jennifer E Vela, Loren Olson, et al.
Antiviral Research|March 18, 2004
Investigating the effects of stereochemistry on incorporation and removal of 5-fluorocytidine analogs by mitochondrial DNA polymerase gamma: comparison of D- and L-D4FC-TPEisuke Murakami, Adrian S Ray, Raymond F Schinazi, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2002
Novel use of a guanosine prodrug approach to convert 2',3'-didehydro-2',3'-dideoxyguanosine into a viable antiviral agentAdrian S Ray, Zhenjun Yang, Chung K Chu, et al.
Antiviral Therapy|October 9, 2008
Effect of nucleoside and nucleotide reverse transcriptase inhibitors of HIV on endogenous nucleotide poolsJennifer E Vela, Michael D Miller, Gerald R Rhodes, et al.
Chemical Research in Toxicology|February 19, 2016
Involvement of Drug Transporters in Organ Toxicity: The Fundamental Basis of Drug Discovery and DevelopmentYaofeng Cheng, Ayman El-Kattan, Yan Zhang, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|November 15, 2006
Simultaneous quantitation of the nucleotide analog adefovir, its phosphorylated anabolites and 2'-deoxyadenosine triphosphate by ion-pairing LC/MS/MSJennifer E Vela, Loren Y Olson, Alan Huang, et al.
Pageof 11

Showing results (11-20 of 103) with videos related to

Sort By:
Pageof 11
The Journal of Biological Chemistry|August 15, 2002
Mechanistic studies to understand the progressive development of resistance in human immunodeficiency virus type 1 reverse transcriptase to abacavirAdrian S Ray, Aravind Basavapathruni, Karen S Anderson
Current Opinion in Drug Discovery & Development|July 3, 2010
HCV NS5B polymerase inhibitorsWilliam J Watkins, Adrian S Ray, Lee S Chong
Toxicological Sciences : an Official Journal of the Society of Toxicology|November 3, 2016
Role of Mitochondrial Toxicity in BMS-986094-Induced ToxicityJoy Y Feng, Chin H Tay, Adrian S Ray
Antiviral Research|December 8, 2015
Tenofovir alafenamide: A novel prodrug of tenofovir for the treatment of Human Immunodeficiency VirusAdrian S Ray, Marshall W Fordyce, Michael J M Hitchcock
Biochemical Pharmacology|September 29, 2004
Effective metabolism and long intracellular half life of the anti-hepatitis B agent adefovir in hepatic cellsAdrian S Ray, Jennifer E Vela, Loren Olson, et al.
Antiviral Research|March 18, 2004
Investigating the effects of stereochemistry on incorporation and removal of 5-fluorocytidine analogs by mitochondrial DNA polymerase gamma: comparison of D- and L-D4FC-TPEisuke Murakami, Adrian S Ray, Raymond F Schinazi, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2002
Novel use of a guanosine prodrug approach to convert 2',3'-didehydro-2',3'-dideoxyguanosine into a viable antiviral agentAdrian S Ray, Zhenjun Yang, Chung K Chu, et al.
Antiviral Therapy|October 9, 2008
Effect of nucleoside and nucleotide reverse transcriptase inhibitors of HIV on endogenous nucleotide poolsJennifer E Vela, Michael D Miller, Gerald R Rhodes, et al.
Chemical Research in Toxicology|February 19, 2016
Involvement of Drug Transporters in Organ Toxicity: The Fundamental Basis of Drug Discovery and DevelopmentYaofeng Cheng, Ayman El-Kattan, Yan Zhang, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|November 15, 2006
Simultaneous quantitation of the nucleotide analog adefovir, its phosphorylated anabolites and 2'-deoxyadenosine triphosphate by ion-pairing LC/MS/MSJennifer E Vela, Loren Y Olson, Alan Huang, et al.
Pageof 11